Banks struggles to justify LG CNS’ IPO valuation There is gap between IT service company’s OTC market value and P/E multiple valuation
Translated by Ryu Ho-joung 공개 2022-05-09 07:58:19
이 기사는 2022년 05월 09일 07:56 thebell 에 표출된 기사입니다.
Investment bankers are struggling to justify a higher valuation for LG CNS than its listed peer Samsung SDS in its planned initial public offering despite its strong earnings growth, as the South Korean information technology services company lacks strengths that differentiate it from its competitors.Investment banks invited by LG CNS to pitch for roles in its IPO put a valuation of between 6 trillion won and 7 trillion won ($5.5 billion) on the company based on what its stock is traded at in the over-the-counter market.
This valuation is higher than Samsung SDS, LG CNS’ closest peer listed on Kospi. Based on Tuesday’s closing price and 633.4 billion won in net profit in 2021, Samsung SDS’ price-to-earnings (P/E) ratio is around 17.7 times. This P/E ratio represents a valuation of only 4 trillion won for LG CNS based on its 2021 net profit.
LG CNS might be able to justify a higher valuation if it has strengths that can differentiate the company from its rivals. One of those strengths was its lower reliance on intercompany transactions.
Intercompany transactions accounted for 59% of LG CNS’ total consolidated revenue in 2019. But the proportion rose to 64% in 2021, closer to 68% for Samsung SDS. The figure could have further increased if revenue from LX Group, which spun off from LG Group in May last year, was included.
LG CNS is also making little progress with its new businesses. In 2019, the company created a data and analytics team as part of efforts to ramp up its cloud computing business. Kim Eun-saeng, former vice president of Dell Technologies, was named to lead the team. But without notable results, Kim stepped down from the role earlier this year.
“It will be difficult for LG CNS to justify the 7 trillion won valuation,” an investment banking source said. “There are not many things that can be done until the IPO except hoping market conditions improve.” (Reporting by Yoon-shin Choi)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [이스트소프트는 지금]'알집' 신화로 세운 종합 ICT그룹 '경고등 켜졌다'
- '사랑의열매' OCIO, NH증권 수성 여부 촉각
- 다올운용 라인업 확대 '총력'…해외재간접 펀드 출시
- [스튜어드십코드 모니터]브이아이운용, 현대엘리 표대결서 이사회측 손들었다
- [스튜어드십코드 모니터]다올운용, 삼성전자 이사 후보 '리스크 관리 미흡'
- [성과연동 펀드판매 확산]당국 눈치보며 쉬쉬…법령해석 재확인후 '본격화' 조짐
- [동구바이오제약 신사업 전략]캐시카우만으론 역부족, 벌크업 기반 '오너 보증 차입'
- [LK삼양 뉴비기닝]그룹 오너 구본욱의 변신, 경쟁력 강화만 본다
- [루키 바이오텍 in market]김권 셀비온 대표"경쟁약 넘는 효능, 품목허가 꿈 도전"
- [Policy Radar]바이오시밀러 문턱 낮춘 유럽, 비용·경쟁 판이 바뀐다